Sub Menu

Press On Fund Grant to MUSC Proves Crucial to Six Clinical Trials

02/13/2018

FOR IMMEDIATE RELEASE:

February 13, 2018

For More Information, Contact:

Turner Simkins, Press On Fund: turner@newfiremedia.com | 706.373.1303

 

Press On Fund Grant to MUSC Proves Crucial to Six Clinical Trials

$50,000 (in 2017)

Augusta, GA – February 13, 2018 – In 2017, Press On granted $50,000 to a study developing immunotherapy treatments for Medulloblastoma, Neuroblastoma, and other solid tumors at Medical University of South Carolina Children’s Health. The grant was a match of a $50,000 donation made by the South Carolina band The Blue Dogs, bringing the total to $100,000. Run by Dr. Jacqueline Kraveka, the study that received the grant is now in clinical trials.

“Support from the Press On Fund has been crucial for MUSC Children’s Health to open and conduct six neuroblastoma and early phase clinical trials,” reports Dr. Kraveka’s team. Three of those trials are Phase I trials – MUSC Children’s Health is the only facility in South Carolina to offer Phase I pediatric cancer trials! Another trial, an exciting pilot study titled the PEDS-PLAN, is the first to incorporate precision medicine into upfront therapy for newly diagnosed high-risk Neuroblastoma. The survival rate for high-risk Neuroblastoma is currently 60% – something Press On and Dr. Kraveka’s team would like to change. There are currently 14 patients enrolled across the six trials, with goals to increase their clinical trial portfolio and enroll more patients in 2018.

 

Back to Top